Induced sputum inflammatory mediator concentrations in chronic cough.

Previous studies have shown evidence of airway inflammation in patients with chronic cough and have suggested that the cough may be due to release of tussive mediators and activation of afferent sensory nerve endings. We measured the concentration of various proinflammatory and tussive mediators in induced sputum supernatants from 20 patients with cough variant asthma or eosinophilic bronchitis, 20 patients with nonasthmatic chronic cough, 22 patients with idiopathic chronic cough, and 18 healthy control subjects. We measured histamine, cysteinyl-leukotrienes, prostanoids (prostaglandin D2 and prostaglandin E2), and interleukin-8 by enzyme immunoassay. The median sputum histamine concentrations were significantly higher in patients with idiopathic chronic cough (8.0 ng/ml) and cough variant asthma/eosinophilic bronchitis (10.2 ng/ml) than in normal subjects (2.6 ng/ml; 95% confidence interval of difference from idiopathic chronic cough, 0.8 to 25.8 [p = 0.009] and 95% confidence interval of difference from cough variant asthma/eosinophilic bronchitis, 1.1 to 20.1 [p = 0.01]). Median sputum prostaglandin D2 and prostaglandin E2 concentrations were significantly higher in all categories of chronic cough. Our findings support the view that there is release of inflammatory and tussive mediators in patients with chronic cough and suggest that there might be similarities in the mechanism of cough in a diverse range of conditions.

[1]  I. Pavord,et al.  Idiopathic chronic cough: association with organ specific autoimmune disease and bronchoalveolar lymphocytosis , 2003, Thorax.

[2]  I. Pavord,et al.  TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis. , 2002, The Journal of allergy and clinical immunology.

[3]  I. Pavord,et al.  Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial , 2002, The Lancet.

[4]  I. Pavord,et al.  Mast-cell infiltration of airway smooth muscle in asthma. , 2002, The New England journal of medicine.

[5]  J. Shim,et al.  Airway inflammation as an assessment of chronic nonproductive cough. , 2001, Chest.

[6]  Eric J. Kunkel,et al.  CCR7 Expression and Memory T Cell Diversity in Humans1 , 2001, The Journal of Immunology.

[7]  R. Irwin,et al.  The diagnosis and treatment of cough. , 2000, The New England journal of medicine.

[8]  I. Pavord,et al.  Induced sputum inflammatory mediator concentrations in eosinophilic bronchitis and asthma. , 2000, American journal of respiratory and critical care medicine.

[9]  I. Pavord,et al.  Induced sputum eicosanoid concentrations in asthma. , 1999, American journal of respiratory and critical care medicine.

[10]  A J Wardlaw,et al.  Eosinophilic bronchitis is an important cause of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[11]  N. Zamel,et al.  Exhaled nitric oxide as a noninvasive assessment of chronic cough. , 1999, American journal of respiratory and critical care medicine.

[12]  I. Pavord,et al.  The safety and success rate of sputum induction using a low output ultrasonic nebuliser. , 1999, Respiratory medicine.

[13]  K. Chung,et al.  Increased neutrophils and cytokines, TNF-α and IL-8, in induced sputum of non-asthmatic patients with chronic dry cough , 1999, Thorax.

[14]  P. Forsythe,et al.  Bronchoalveolar lavage findings in patients with chronic nonproductive cough. , 1999, The European respiratory journal.

[15]  M. Ennis,et al.  Evaluation and outcome of patients with chronic non-productive cough using a comprehensive diagnostic protocol , 1998, Thorax.

[16]  L. Boulet,et al.  Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. , 1998, Chest.

[17]  W. Sewell,et al.  Chronic cough resembles asthma with IL-5 and granulocyte-macrophage colony-stimulating factor gene expression in bronchoalveolar cells. , 1998, The Journal of allergy and clinical immunology.

[18]  I. Pavord,et al.  The use of induced sputum to investigate airway inflammation. , 1997, Thorax.

[19]  F. Hargreave,et al.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.

[20]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[21]  K. Hirata,et al.  Effect of loratadine, an H1 antihistamine, on induced cough in non-asthmatic patients with chronic cough. , 1996, Thorax.

[22]  J. Oates,et al.  Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. , 1994, American journal of respiratory and critical care medicine.

[23]  L. Boulet,et al.  Airway inflammation in nonasthmatic subjects with chronic cough. , 1994, American journal of respiratory and critical care medicine.

[24]  T. Haahtela,et al.  Leukotriene E4 and granulocytic infiltration into asthmatic airways , 1993, The Lancet.

[25]  S. Holgate,et al.  Terfenadine, a potent histamine H1-receptor antagonist in the treatment of grass pollen sensitive asthma. , 1990, British journal of clinical pharmacology.

[26]  E. Bleecker,et al.  Evidence for elevated levels of histamine, prostaglandin D2, and other bronchoconstricting prostaglandins in the airways of subjects with mild asthma. , 1990, The American review of respiratory disease.

[27]  N. Choudry,et al.  Sensitivity of the human cough reflex: effect of inflammatory mediators prostaglandin E2, bradykinin, and histamine. , 1989, The American review of respiratory disease.

[28]  S. Peters,et al.  Purified human basophils and mast cells: current concepts of mediator release. , 1983, European journal of respiratory diseases. Supplement.